name,pdb_id,pubmed_id,resolution,uniprot,PFAM,CATH,receptor_chain,receptor_length,peptide_chain,peptide_length,sequence_alignment,stride,percent_exposed_alignment,cluster_number,binding_mode,size_of_binding_mode,core_ecr_alignment,longest_continuous_core,longest_continuous_ecr,corebinding_aa,exosite_aa,surface_aa,interior_aa,corebinding_ss,exosite_ss,surface_ss,interior_ss,unique_id,COREBINDING_aa,COREBINDING_ss,EXOSITE_aa,EXOSITE_ss,bfact,bs_loc_type,full_peptide_sequece,mean_seq_iden_in_bm,mean_seq_iden_not_bm,min_dist_E_C_diff_bm,occupancy,pep_loc_type,title
1CA0_GH_F_10_1.pdb,1CA0,9300481,2.10,P00766,,2.40.10.10,GH,228,F,11,--CGVPAIQ------PVLS----------,--CCCTTTT------CCCC----------,--2020212------0114----------,10,1,5,--CCCCCCC------CCCe----------,10,1,A:0;C:0;G:0;P:0;Q:0;S:0;V:0;W:0,A:0;C:0;G:0;P:0;Q:0;S:0;V:0;W:0,A:3;D:2;E:1;F:1;G:2;K:7;L:1;M:1;N:2;Q:1;R:1;S:10;T:6;Y:1,A:16;C:8;D:7;E:4;F:5;G:17;H:2;I:9;K:7;L:16;M:1;N:11;P:5;Q:6;R:2;S:15;T:16;V:18;W:5;Y:3,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,B:2;C:6;E:5;G:1;H:5;T:20,B:8;C:25;E:73;G:8;H:12;T:47,10_1,A:2;C:1;G:2;P:2;Q:2;S:1;V:3;W:3,B:1;C:2;E:4;T:9,A:0;C:0;G:0;P:0;Q:0;S:0;V:0;W:0,B:0;C:0;E:0;T:0,--6655878------8888----------,ALA_105_G_COREBINDING;ALA_58_H_COREBINDING;CYS_107_G_COREBINDING;GLN_101_G_COREBINDING;GLN_9_H_COREBINDING;GLY_10_G_COREBINDING;GLY_57_H_COREBINDING;PRO_13_G_COREBINDING;PRO_9_G_COREBINDING;SER_11_G_COREBINDING;TRP_12_G_COREBINDING;TRP_14_G_COREBINDING;TRP_59_H_COREBINDING;VAL_106_G_COREBINDING;VAL_122_G_COREBINDING;VAL_8_G_COREBINDING,CGVPAIQPVLSGL,0.836345381526104,-1,NA,--9999999------9999----------,CYS_1_F_C;GLY_2_F_C;VAL_3_F_C;PRO_4_F_C;ALA_5_F_C;ILE_6_F_C;GLN_7_F_C;PRO_8_F_C;VAL_9_F_C;LEU_10_F_C;SER_11_F_e,"BOVINE CHYMOTRYPSIN COMPLEXED TO APPI"
1CHO_FG_E_10_1.pdb,1CHO,3477645,1.80,P00766,,2.40.10.10,FG,228,E,10,--CGVPAIQ------PVL-----------,--CCCTTTT------CCC-----------,--3020303------022-----------,10,1,5,--CCCCCCC------CCC-----------,10,0,A:0;C:0;E:0;G:0;P:0;Q:0;S:0;T:0;V:0;W:0,A:0;C:0;E:0;G:0;P:0;Q:0;S:0;T:0;V:0;W:0,A:3;D:2;F:1;G:2;K:8;L:1;N:2;Q:1;R:1;S:10;T:5;Y:2,A:16;C:8;D:7;E:4;F:5;G:17;H:2;I:9;K:6;L:16;M:2;N:11;P:5;Q:6;R:2;S:14;T:16;V:18;W:5;Y:2,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,B:1;C:5;E:5;G:2;H:7;T:18,B:7;C:27;E:71;G:7;H:12;T:47,10_1,A:2;C:1;E:1;G:2;P:2;Q:2;S:2;T:1;V:3;W:3,B:1;C:2;E:6;T:10,A:0;C:0;E:0;G:0;P:0;Q:0;S:0;T:0;V:0;W:0,B:0;C:0;E:0;T:0,--5455555------578-----------,ALA_105_F_COREBINDING;ALA_58_G_COREBINDING;CYS_107_F_COREBINDING;GLN_101_F_COREBINDING;GLN_9_G_COREBINDING;GLU_5_F_COREBINDING;GLY_10_F_COREBINDING;GLY_57_G_COREBINDING;PRO_13_F_COREBINDING;PRO_9_F_COREBINDING;SER_11_F_COREBINDING;SER_11_G_COREBINDING;THR_102_F_COREBINDING;TRP_12_F_COREBINDING;TRP_14_F_COREBINDING;TRP_59_G_COREBINDING;VAL_106_F_COREBINDING;VAL_122_F_COREBINDING;VAL_8_F_COREBINDING,CGVPAIQPVLSGL,0.836345381526104,-1,,--9999999------999-----------,CYS_1_E_C;GLY_2_E_C;VAL_3_E_C;PRO_4_E_C;ALA_5_E_C;ILE_6_E_C;GLN_7_E_C;PRO_8_E_C;VAL_9_E_C;LEU_10_E_C,"CRYSTAL AND MOLECULAR STRUCTURES OF THE COMPLEX OF ALPHA 2 CHYMOTRYPSIN WITH ITS INHIBITOR TURKEY OVOMUCOID THIRD 3 DOMAIN AT 18 ANGSTROMS RESOLUTION"
1RIW_BC_A_10_1.pdb,1RIW,15137772,2.04,P00734,,2.40.10.10,BC,249,A,27,ADCGLRPLFEKKSLEDKT-ERELLESYI-,CTTTTTTTTGGGCCCCCH-HHHHHHHTT-,511000000022322020-021023014-,10,1,5,eeCCCCCCCEEEEEEccc-EEEEEEEEE-,7,9,C:0;D:1;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:1;V:0;W:0;Y:0,C:0;D:0;E:0;G:0;H:0;I:0;K:0;L:0;M:0;N:0;P:0;R:0;S:0;V:0;W:0;Y:0,A:2;D:6;E:2;F:2;G:2;K:4;N:3;P:3;Q:3;R:8;S:2;T:2;W:1;Y:1,A:9;C:6;D:8;E:11;F:6;G:15;H:4;I:15;K:11;L:19;M:6;N:4;P:8;Q:5;R:8;S:8;T:7;V:15;W:5;Y:6,B:0;C:0;E:2;H:0;T:0,B:0;C:0;E:0;H:0;T:0,C:10;E:1;G:2;H:10;T:18,B:7;C:25;E:76;G:8;H:10;T:50,10_1,C:1;D:1;E:1;G:1;H:1;I:1;K:0;L:0;M:1;N:2;P:2;R:2;S:2;V:1;W:2;Y:1,B:2;C:4;E:2;H:0;T:11,C:0;D:0;E:0;G:2;H:0;I:0;K:3;L:1;M:0;N:1;P:1;R:0;S:1;V:0;W:0;Y:2,B:0;C:2;E:5;H:2;T:2,654333334444455455-555567788-,ARG_137_B_COREBINDING;ARG_64_C_COREBINDING;ASN_10_C_EXOSITE;ASN_62_C_COREBINDING;ASN_63_C_COREBINDING;ASP_113_B_COREBINDING;ASP_6_B_corebinding;CYS_119_B_COREBINDING;GLU_8_B_COREBINDING;GLY_10_B_COREBINDING;GLY_133_B_EXOSITE;GLY_136_B_EXOSITE;HIS_116_B_COREBINDING;ILE_9_B_COREBINDING;LEU_129_B_EXOSITE;LYS_135_B_EXOSITE;LYS_42_C_EXOSITE;LYS_58_C_EXOSITE;MET_11_B_COREBINDING;PRO_117_B_COREBINDING;PRO_13_B_COREBINDING;PRO_60_C_EXOSITE;SER_112_B_COREBINDING;SER_12_B_COREBINDING;SER_128_B_EXOSITE;SER_5_B_corebinding;TRP_14_B_COREBINDING;TRP_65_C_COREBINDING;TYR_114_B_COREBINDING;TYR_134_B_EXOSITE;TYR_36_C_EXOSITE;VAL_118_B_COREBINDING,TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR,0.345381526104418,-1,NA,999999999999999999-999999999-,ALA_1_A_e;ASP_2_A_e;CYS_3_A_C;GLY_4_A_C;LEU_5_A_C;ARG_6_A_C;PRO_7_A_C;LEU_8_A_C;PHE_9_A_C;GLU_10_A_E;LYS_11_A_E;LYS_12_A_E;SER_13_A_E;LEU_14_A_E;GLU_15_A_E;ASP_16_A_c;LYS_17_A_c;THR_18_A_c;GLU_19_A_E;ARG_20_A_E;GLU_21_A_E;LEU_22_A_E;LEU_23_A_E;GLU_24_A_E;SER_25_A_E;TYR_26_A_E;ILE_27_A_E,"THROMBIN IN COMPLEX WITH NATURAL PRODUCT INHIBITOR OSCILLARIN"
1YPH_DF_B_10_1.pdb,1YPH,,1.34,P00766,,2.40.10.10,DF,228,B,12,--CGVPAIQ------PVLS---------G,--CCCTTTT------CCCC---------C,--3020212------0213---------3,10,1,5,--CCCCCCC------CCCe---------e,10,2,A:0;C:0;E:0;G:0;P:0;Q:0;S:0;T:0;V:0;W:0,A:0;C:0;E:0;G:0;P:0;Q:0;S:0;T:0;V:0;W:0,A:3;D:2;E:1;F:1;G:2;K:8;L:1;M:1;N:2;Q:1;R:1;S:7;T:6;Y:2,A:16;C:8;D:7;E:3;F:5;G:17;H:2;I:9;K:6;L:16;M:1;N:11;P:5;Q:6;R:2;S:17;T:15;V:18;W:5;Y:2,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:8;E:4;G:2;H:6;T:18,B:6;C:25;E:72;G:7;H:13;T:48,10_1,A:2;C:1;E:1;G:2;P:2;Q:2;S:2;T:1;V:3;W:3,B:1;C:2;E:6;T:10,A:0;C:0;E:0;G:0;P:0;Q:0;S:0;T:0;V:0;W:0,B:0;C:0;E:0;T:0,--5555666------5589---------9,ALA_105_D_COREBINDING;ALA_58_F_COREBINDING;CYS_107_D_COREBINDING;GLN_101_D_COREBINDING;GLN_9_F_COREBINDING;GLU_5_D_COREBINDING;GLY_10_D_COREBINDING;GLY_57_F_COREBINDING;PRO_13_D_COREBINDING;PRO_9_D_COREBINDING;SER_11_D_COREBINDING;SER_11_F_COREBINDING;THR_102_D_COREBINDING;TRP_12_D_COREBINDING;TRP_14_D_COREBINDING;TRP_59_F_COREBINDING;VAL_106_D_COREBINDING;VAL_122_D_COREBINDING;VAL_8_D_COREBINDING,CGVPAIQPVLSGL,0.836345381526104,-1,NA,--9999999------9999---------9,CYS_1_B_C;GLY_2_B_C;VAL_3_B_C;PRO_4_B_C;ALA_5_B_C;ILE_6_B_C;GLN_7_B_C;PRO_8_B_C;VAL_9_B_C;LEU_10_B_C;SER_11_B_e;GLY_12_B_e,"HIGH RESOLUTION STRUCTURE OF BOVINE ALPHACHYMOTRYPSIN"
2CHA_FG_E_10_1.pdb,2CHA,5069789,2.00,P00766,,2.40.10.10,FG,228,E,8,--CGVPAIQ------P-------------,--CCCTTTT------C-------------,--3020213------1-------------,10,1,5,--CCCCCCC------C-------------,8,0,A:0;C:0;G:0;P:0;Q:0;S:0;T:0;V:0;W:0,A:0;C:0;G:0;P:0;Q:0;S:0;T:0;V:0;W:0,A:4;D:2;E:1;F:2;G:3;K:9;L:1;M:1;N:2;Q:1;R:1;S:8;T:5;W:1;Y:2,A:15;C:8;D:7;E:4;F:4;G:16;H:2;I:9;K:5;L:16;M:1;N:11;P:5;Q:7;R:2;S:17;T:16;V:20;W:6;Y:2,B:0;C:0;E:0;T:0,B:0;C:0;E:0;T:0,C:9;E:7;G:2;H:5;T:20,B:4;C:26;E:69;G:7;H:10;T:57,10_1,A:2;C:1;G:2;P:2;Q:1;S:1;T:1;V:1;W:1,B:1;C:1;E:1;T:9,A:0;C:0;G:0;P:0;Q:0;S:0;T:0;V:0;W:0,B:0;C:0;E:0;T:0,---------------------,ALA_105_F_COREBINDING;ALA_58_G_COREBINDING;CYS_107_F_COREBINDING;GLN_101_F_COREBINDING;GLY_10_F_COREBINDING;GLY_57_G_COREBINDING;PRO_13_F_COREBINDING;PRO_9_F_COREBINDING;SER_11_F_COREBINDING;THR_102_F_COREBINDING;TRP_59_G_COREBINDING;VAL_8_F_COREBINDING,CGVPAIQPVLSGL,0.836345381526104,-1,,---------------------,CYS_1_E_C;GLY_2_E_C;VAL_3_E_C;PRO_4_E_C;ALA_5_E_C;ILE_6_E_C;GLN_7_E_C;PRO_8_E_C,"THE STRUCTURE OF CRYSTALLINE ALPHACHYMOTRYPSIN VTHE ATOMIC 2 STRUCTURE OF TOSYLALPHACHYMOTRYPSIN AT 2 ANGSTROMS RESOLUTION"
